Abstract:
The field of cancer research and treatment is rapidly evolving, presenting significant challenges in modern oncology. In response, the Tumori Journal launched a Call for Papers to identify high-quality manuscripts that offer advanced and innovative insights into cancer research and treatment. The focus was on three key areas: the clinical relevance of personalized treatment for cancer patients, prospective clinical trials in oncology, and the validation of predictive biomarkers in cancer.
We are pleased to announce the three winning articles from the Call for Papers, “Advancing and Innovating in Cancer Care,” which have been awarded free registration to the ESMO 2024 Congress. These papers have made significant contributions to the field by exploring the monitoring of clinically relevant methylated genes in colorectal cancer, stereotactic body radiation treatment, and the use of predictive biomarkers for personalized treatment of solid tumors. These innovative approaches offer new perspectives on patient care and have the potential to significantly improve treatment outcomes.
Enjoy your reading!
Prof. Giancarlo Pruneri
Editor in Chief Tumori Journal